# Blossom Pharmaceuticals – FDA Inspection, Apr 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/blossom-pharmaceuticals/15f86524-6141-481d-b505-0f7ff617faee
Source feed: FDA_Inspections

> FDA inspection 1273155 of Blossom Pharmaceuticals, April 11, 2025. Classification: Official Action Indicated (OAI). 7 citations under 21 CFR part 211. Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1273155
- Company Name: Blossom Pharmaceuticals
- Inspection Date: 2025-04-11
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 7

## Related Documents

- [FDA Inspection 1084385 - 2019-02-14](https://www.keypedia.com/records/fda_inspections/blossom-pharmaceuticals/36661a4b-c204-469e-a7c6-7d10272edaa1)
- [FDA Inspection 998364 - 2016-12-16](https://www.keypedia.com/records/fda_inspections/blossom-pharmaceuticals/0a673663-2f3c-4f19-b939-a2864c6bb6c7)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/kellia-n-hicks/44104c4a-70c1-47fc-9a77-c09c41bacc2b)

Company: https://www.keypedia.com/companies/blossom-pharmaceuticals/14aebe73-3f72-4eab-8ca2-6e16c3262b19

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8
